Why it matters: In-house testing, while important, has an inherent limitation: the entity performing the test has a financial interest in the result
After reconstitution with a suitable diluent, the peptide can be measured more accurately
Potential FDA approval around 2027-2028
By enhancing the effects of GLP-1, semaglutide helps you eat less, feel more satisfied, and manage your blood sugar more effectively
Administration of this peptide has been associated with the release of serotonin in specific brain regions, notably the nigrostriatal areas, and has beneficial effects on dopaminergic systems
Although the recent approval of resmetirom shows promise, its long-term efficacy and economic feasibility remain unclear